Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists—a nationwide population-based cohort study based on 2010–2013 French Health Insurance data

Complete list of metadatas

https://hal.univ-brest.fr/hal-02051031
Contributor : Ghislaine Calvez <>
Submitted on : Wednesday, February 27, 2019 - 3:15:03 PM
Last modification on : Wednesday, April 24, 2019 - 3:52:43 PM

Identifiers

Citation

Lucie-Marie Scailteux, Sébastien Vincendeau, Frédéric Balusson, Christophe Leclercq, André Happe, et al.. Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists—a nationwide population-based cohort study based on 2010–2013 French Health Insurance data. European Journal of Cancer, Elsevier, 2017, 77, pp.99-108. ⟨10.1016/j.ejca.2017.03.002⟩. ⟨hal-02051031⟩

Share

Metrics

Record views

24